Quantum-entropy optimization demonstrates a strong link between purity and entropy in Tc-99m, suggesting improved radiopharmaceutical design.
Abstract Technetium-99m (⁹⁹ᵐTc) radiopharmaceuticals account for more than 80% of diagnostic nuclear medicine procedures, yet their design has remained largely empirical, with minimal integration of quantum-mechanical stability. We present a quantum-entropy optimization framework demonstrating a statistically robust inverse correlation (ρ = -0.76 ± 0.05,p < 0.001) between Rényi-2 entropy (S₂) and quantum state purity (Tr[ρ²]) across ⁹⁹ᵐTc decay pathways. To formalize this relationship and for further research, we propose QCuries (Quantum Curies) as a unit for quantifying quantum-augmented activity, defined as 1 QCurie = 1 Curie × (1 - e⁻ᴿᵉ[ρ]), which reduces to the classical Curie under full decoherence. Our hybrid quantum-classical neural networks (QNN–ANN), trained on ab initio Nikiforov–Uvarov solutions and data from Nuclear information repositories, achieves a 32% accuracy gain over classical ANN baselines in stability and information-theoretic parameter predictions. Predicted phenomena include a 660-attosecond coherence threshold for β⁻ decay, high-purity α emissions (98% at 0.25 nat entropy), and >18% deviations from linear dosimetry in high-entropy regimes(S₂ > 1.5 nat). These results reveal a computationally defined ‘quantum Goldilocks zone’(0.5 < S₂ < 1.5 nat; 0.7-1.2 QCuries), which may guide the optimization of diagnostic tracers pending clinical validation. While clinical validation remains ongoing, this framework provides a physics-grounded path toward more predictive radiopharmaceutical design and may guide future regulatory standards.
No takes yet. Share an insight, caveat, or question.
Yahweh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: